Eurofins Pharma services newsletter 07 - February 2014
ARTICLES:
- Argos Therapeutics earns global regulatory approval with Eurofins
Lancaster Laboratories' rapid mycoplasma MilliPROBE® assay - UV-C Inactivation: A new viral inactivation method for biopharmaceuticals
- Which Antimicrobial Efficacy Study is best for your product?
- How will the new EU 528/2013 regulation affect biocidal products testing?
- Toxicological evaluation: the bridge between extractables and leachables
- MIND THE GAP between ISO 10993 and submission to FDA
- Pharma Events
Download the pdf version of the newsletter
Receive the next newsletter via email
